Skvarka Jan - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 21, 2024, Skvarka Jan's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Director, and currently has 89,551 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Skvarka Jan - Insider Non-Derivative Transactions of ZNTL Common Stock
Skvarka Jan - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 22, 2024 | Acquisition -- (Common Stock) | 41581 | 0 | 89551 |
| Sep 12, 2023 | Sell -- (Common Stock) | 5000 | 25.05 | 47970 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 16364 | 0 | 52970 |